The clinical, social, and economic impacts of the coronavirus disease 2019 (COVID-19)
pandemic, originated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Introduction Drug repositioning is a strategy to identify a new therapeutic indication for
molecules that have been approved for other conditions, aiming to speed up the traditional …

The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

In this review, we investigated whether severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) can directly cause myocarditis with severe myocardial damage induced by …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has prompted significant
changes in patient care in rheumatology and gastroenterology, with clinical guidance issued …

Janus kinases (JAK) are a family of tyrosine kinases (JAK1, JAK2, JAK3, and TYK2) that
transduce cytokine-mediated signals through the JAK–STAT metabolic pathway. These …

Coronavirus disease 2019 is a rather heterogeneous disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The ongoing pandemic is a global threat …

The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel
coronavirus, partially similar to previously known coronaviruses but with a different pattern of …

Die Lebertransplantation ist eine lebensrettende Option für Patienten mit Leberzirrhose,
hepatozellulärem Karzinom, genetischen, metabolischen oder cholestatischen …

Background JAK (Janus kinases) inhibitors have been proposed as a promising treatment
option for the coronavirus disease-2019 (COVID-19). However, the benefits of JAK inhibitors …